Antibiotic C3368-A, a fungus-derived nucleoside transport inhibitor, potentiates the activity of antitumor drugs

Cancer Chemotherapy and Pharmacology

Volumn 36, Issue 2, 1995, Pages 149-154

  Su, Jian ^a   Zhen, Yong su ^a   Qi, Chang qing ^a   Hu, Ji lan ^a  

^a INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

Author keywords

Antitumor drug activity; CA; Nucleoside transport inhibitor; Synergism

Indexed keywords

ANTIBIOTIC AGENT; ANTIBIOTIC C 3368A; ANTINEOPLASTIC AGENT; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; MITOMYCIN C; NUCLEOSIDE TRANSPORT INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER; CELL STRAIN KB; CLONOGENIC ASSAY; CONTROLLED STUDY; DRUG POTENTIATION; EHRLICH ASCITES TUMOR; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; BENZOFURANS; BIOLOGICAL TRANSPORT; CARCINOMA, EHRLICH TUMOR; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; COLONIC NEOPLASMS; COMPARATIVE STUDY; DOXORUBICIN; DRUG SYNERGISM; FEMALE; FLUOROURACIL; HUMAN; KB CELLS; LIVER NEOPLASMS; METHOTREXATE; MICE; MICE, INBRED BALB C; MITOMYCIN; THYMIDINE; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; URIDINE;

EID: 0029040158     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/BF00689200     Document Type: Article

References (35)

1. Dipyridamole (D) potentiation of FUdR antitumor IIID-3 activity
2. Phase II trial of PALA+dipyridamole in patients with metastatic soft tissue sarcoma
3. Phase I trial of dipyridamole with 5-fluorouracil and folinic acid
4. Effects of dipyridamole on fluorodeoxyuridine cytotoxicity in vitro and in cancer patients
5. Potentiation of anitmetabolite antitumor activity in vivo by dipyridamole and amphotericin B
6. Modulation of the activity of PALA by dipyridamole
7. Uridine pharmacokinetics in cancer patients
8. Studies on antibiotics from Chrysosporium sp. strain C3368, one of the psychrophiles from Antarctica. II Isolation and structure determination of antibiotic C3368
9. Advances in rational combination chemotherapy
10. Nucleoside salvage and resistance to antimetabolite anticancer agents
11. Disparate in vivo impact of the chemosensitizer dipyridamole on the therapeutic index of cisplatin, carboplatin, and etoposide. A preclinical evaluation using a human bladder cancer xenograft model
12. Selective intraperitoneal biochemical modulation of methotrexate by dipyridamole
13. Oral dipyridamole and methotrexate in human solid tumors: a toxicity trial
14. Synergistic inhibitory effects of dipyridamole and vincristine on the growth of human leukaemia and lymphoma cell lines
15. Comparison of the synergistic potentiation of etoposide, doxorubicin and vinblastine cytotoxicity by dipyridamole
16. Biological characteristics and biological activity of soil microorganisms from Antarctic King George Island
17. Potentiation of methotrexate lymphocytotoxicity in vitro by inhibitors of nucleoside transport
18. Synergism between dipyridamole and cisplatin in human ovarian carcinoma cells in vitro
19. Dipyridamole-cisplatin potentiation:enhanced in vivo cytotoxicity in xenograft models of human testicular and bladder cancers
20. Potentiation of adriamycin cytotoxicity by dipyridamole against HeLa cells in vitro and sarcoma 180 cells in vivo
21. Measurement of cell numbers by means of the endogenuous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens
22. Augmentation of methotrexate cytotoxicity in human colon cancer cells achieved through inhibition of thymidine salvage by dipyridamole
23. Salvage of circulating pyrimidine nucleosides in the rat
24. Potentiation of methotrexate toxicity by dipyridamole
25. The effect of the nucleoside transport inhibitor dipyridamole on the incorporation of [3H]thymidine in the rat
26. Dipyridamole potentiates the growth-inhibitory action of methotrexate and 5-fluorouracil in human keratinocytes in vitro
27. Reduction of hepatotoxicity from intraarterial 2′, 5-fluorodexoyuridine (FudR) by dipyridamole (DP)
28. Modulation of drug sensitivity by dipyridamole in multidrug resistant tumor cells in vitro
29. Modulation of vinblastine sensitivity by dipyridamole in multidrug resistant fibrosarcoma cells lacking mdrl expression
30. Sequence-dependent synergism between dichloromethotrexate and cisplatin in a human colon carcinoma cell line
31. Biochemical strategy of cancer cells and the design of chemotherapy: G.H.A. Clowes Memorial Lecture
32. Salvage pathoways as targets of chemotherapy
33. Effects of acivicin and dipyridamole on hepatoma 3924A cells
34. Green tea extract inhibits nucleoside transport and potentiates the antitumor effect of antimetabolites
35. Azidothymidine and dipyridamole as biochemical response modifiers: synergism with methotrexate and 5-fluorouracil in human colon and pancreatic carcinoma cells